Local effects of human PCSK9 on the atherosclerotic lesion

The Journal of Pathology
Ilaria GiunzioniSergio Fazio

Abstract

Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes atherosclerosis by increasing low-density lipoprotein (LDL) cholesterol levels through degradation of hepatic LDL receptor (LDLR). Studies have described the systemic effects of PCSK9 on atherosclerosis, but whether PCSK9 has local and direct effects on the plaque is unknown. To study the local effect of human PCSK9 (hPCSK9) on atherosclerotic lesion composition, independently of changes in serum cholesterol levels, we generated chimeric mice expressing hPCSK9 exclusively from macrophages, using marrow from hPCSK9 transgenic (hPCSK9tg) mice transplanted into apoE(-/-) and LDLR(-/-) mice, which were then placed on a high-fat diet (HFD) for 8 weeks. We further characterized the effect of hPCSK9 expression on the inflammatory responses in the spleen and by mouse peritoneal macrophages (MPM) in vitro. We found that MPMs from transgenic mice express both murine (m) Pcsk9 and hPCSK9 and that the latter reduces macrophage LDLR and LRP1 surface levels. We detected hPCSK9 in the serum of mice transplanted with hPCSK9tg marrow, but did not influence lipid levels or atherosclerotic lesion size. However, marrow-derived PCSK9 progressively accumulated in lesions of apoE(-/-) rec...Continue Reading

References

Jul 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D K StricklandW S Argraves
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·S IshibashiM S Brown
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S FazioM F Linton
Aug 7, 1998·Atherosclerosis·T P Hiltunen, S Ylä-Herttuala
Jun 26, 1999·The Journal of Biological Chemistry·M F LintonS Fazio
Oct 16, 1999·Circulation Research·Z MallatA Tedgui
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 6, 2003·Nature Genetics·Marianne AbifadelCatherine Boileau
Nov 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Duane R Wesemann, Etty N Benveniste
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cord SunderkötterPieter J M Leenen
May 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kara N Maxwell, Jan L Breslow
Jun 26, 2004·Journal of Leukocyte Biology·Robert D Stout, Jill Suttles
Mar 18, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Xiong Z RuanZac Varghese
Jun 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Filip K SwirskiRalph Weissleder
Jan 4, 2007·The Journal of Clinical Investigation·Frank TackeGwendalyn J Randolph
Jan 4, 2007·The Journal of Clinical Investigation·Filip K SwirskiMikael J Pittet
Feb 17, 2007·Circulation Research·Cheryl D OvertonSergio Fazio
Jan 17, 2008·Biochemistry·Daping FanSergio Fazio
Jul 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ahmed ZaidAnnik Prat
Sep 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marie BenoitJean-Louis Mege
Oct 25, 2008·Cardiovascular Drugs and Therapy·Prediman K Shah
Feb 13, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Patricia G YanceySergio Fazio
Dec 8, 2010·Critical Reviews in Eukaryotic Gene Expression·Narayanan Parameswaran, Sonika Patial
Jul 11, 2012·Journal of Cellular Physiology·Guangwei Liu, Hui Yang
Feb 7, 2013·BMC Immunology·Changqi WangDavid Ch Harris
Aug 21, 2014·Journal of Lipid Research·Susan KühnastHans M G Princen
Oct 17, 2014·Science Translational Medicine·Keith R WalleyJohn H Boyd
Nov 21, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Ziad Mallat

❮ Previous
Next ❯

Citations

Dec 8, 2015·Expert Review of Cardiovascular Therapy·Ida GregersenPål Aukrust
Jun 1, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Jia ZhangShu Wang
Aug 9, 2016·Cardiovascular Research·Giuseppe Danilo NorataAlberico L Catapano
Jun 10, 2016·Scientific Reports·Andreea MilasanCatherine Martel
Dec 25, 2016·Expert Review of Cardiovascular Therapy·Fabien HuetFrançois Roubille
Mar 18, 2017·Journal of Atherosclerosis and Thrombosis·Michael D Shapiro, Sergio Fazio
Jun 3, 2017·Journal of Cellular Physiology·Farzad KhademiAmirhossein Sahebkar
Jun 2, 2016·Journal of Cardiovascular Pharmacology and Therapeutics·Wenguang WangHongliang Cong
Mar 12, 2018·Current Atherosclerosis Reports·Angelos D KaragiannisYiannis S Chatzizisis
Jan 3, 2018·The Journal of Infectious Diseases·Hua Ling SunCui Huang
Apr 5, 2018·Cardiovascular Research·Zufeng DingJawahar L Mehta
Dec 7, 2017·The EPMA Journal·Michał WicińskiGrzegorz Grześk
May 16, 2018·European Journal of Preventive Cardiology·José TuñónUNKNOWN ESC Working Group on Atherosclerosis and Vascular Biology
Jul 12, 2018·Current Opinion in Lipidology·Theodosios D FilippatosMoses S Elisaf
Sep 25, 2018·Journal of Cellular Physiology·Zhi-Han TangXi-Long Zheng
Oct 28, 2018·Nature Reviews. Endocrinology·Robert M StoekenbroekG Kees Hovingh
Feb 1, 2019·Circulation Research·Robert S RosensonWolfgang Koenig
Feb 6, 2018·Scientific Reports·Chiara RicciNicola Ferri
Mar 16, 2019·Canadian Journal of Physiology and Pharmacology·Leila SafaeianNasim Dana
Apr 6, 2019·Journal of Cellular Physiology·Xing LiuGuangPing Li
Mar 29, 2018·Current Medicinal Chemistry·Takuro Miyazaki, Akira Miyazaki
Jun 6, 2019·Journal of Internal Medicine·J RannikkoM Pesu
Jul 30, 2019·Oxidative Medicine and Cellular Longevity·Patricia MarchioMaria D Mauricio
Aug 30, 2019·British Journal of Pharmacology·Toshiyuki Nishikido, Kausik K Ray
Aug 11, 2019·Current Topics in Medicinal Chemistry·Bo ChenPengjun Zhao
Nov 21, 2019·Cardiovascular Research·Zufeng DingJawahar L Mehta
Feb 25, 2020·Critical Reviews in Food Science and Nutrition·Rana ShafabakhshZatollah Asemi
Nov 30, 2019·International Angiology : a Journal of the International Union of Angiology·Hana KubátováJan Piťha
Dec 31, 2019·Journal of Immunology Research·Hailin XuZhigang Chen
Apr 26, 2017·Basic Research in Cardiology·Simon GlerupKlaus-Dieter Schlüter
Jan 24, 2019·Clinical Science·Natalie C WardGerald F Watts
Jun 27, 2019·European Heart Journal. Cardiovascular Pharmacotherapy·Amir Abbas Momtazi-BorojeniAmirhossein Sahebkar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.